RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025
RxSight Inc (NASDAQ: RXST), an ophthalmic medical device company focused on providing customized vision solutions for post-cataract surgery patients, has scheduled its Q1 2025 financial results announcement for May 7, 2025 after market close.
The company will host a conference call at 1:30 PM Pacific Time / 4:30 PM Eastern Time to discuss the results. Investors can participate by dialing (800) 715-9871 or (646) 307-1963 with conference code 8740296. A live audio-only webcast will be available through the investor relations website, with a recording accessible afterward.
RxSight Inc (NASDAQ: RXST), un'azienda di dispositivi medici oftalmici specializzata in soluzioni visive personalizzate per pazienti post-intervento di cataratta, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per il 7 maggio 2025 dopo la chiusura del mercato.
L'azienda terrà una conference call alle 13:30 ora del Pacifico / 16:30 ora dell'Est per discutere i risultati. Gli investitori potranno partecipare chiamando il numero (800) 715-9871 o (646) 307-1963 con il codice di conferenza 8740296. Sarà disponibile una webcast audio in diretta tramite il sito delle relazioni con gli investitori, con la registrazione accessibile successivamente.
RxSight Inc (NASDAQ: RXST), una empresa de dispositivos médicos oftálmicos enfocada en ofrecer soluciones visuales personalizadas para pacientes post-cirugía de cataratas, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 7 de mayo de 2025 después del cierre del mercado.
La compañía realizará una llamada conferencia a las 1:30 PM hora del Pacífico / 4:30 PM hora del Este para discutir los resultados. Los inversionistas pueden participar llamando al (800) 715-9871 o (646) 307-1963 con el código de conferencia 8740296. Habrá una transmisión en vivo solo de audio disponible a través del sitio web de relaciones con inversionistas, con una grabación accesible posteriormente.
RxSight Inc(NASDAQ: RXST)는 백내장 수술 후 환자들을 위한 맞춤형 시력 솔루션을 제공하는 안과 의료기기 회사로, 2025년 1분기 재무 실적 발표를 2025년 5월 7일 장 마감 후에 예정하고 있습니다.
회사는 태평양 표준시 오후 1시 30분 / 동부 표준시 오후 4시 30분에 실적을 논의하기 위한 컨퍼런스 콜을 개최할 예정입니다. 투자자는 (800) 715-9871 또는 (646) 307-1963으로 전화해 회의 코드 8740296을 입력하여 참여할 수 있습니다. 투자자 관계 웹사이트를 통해 오디오 생중계가 제공되며, 이후 녹음본도 이용 가능합니다.
RxSight Inc (NASDAQ : RXST), une entreprise de dispositifs médicaux ophtalmiques spécialisée dans les solutions personnalisées pour les patients après une chirurgie de la cataracte, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le 7 mai 2025 après la clôture du marché.
La société organisera une conférence téléphonique à 13h30 heure du Pacifique / 16h30 heure de l’Est pour discuter des résultats. Les investisseurs peuvent participer en appelant le (800) 715-9871 ou le (646) 307-1963 avec le code de conférence 8740296. Un webcast audio en direct sera disponible via le site des relations investisseurs, avec un enregistrement accessible ensuite.
RxSight Inc (NASDAQ: RXST), ein Unternehmen für ophthalmologische Medizinprodukte, das sich auf maßgeschneiderte Sehlösungen für Patienten nach Kataraktoperationen spezialisiert hat, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für den 7. Mai 2025 nach Börsenschluss geplant.
Das Unternehmen wird um 13:30 Uhr Pazifischer Zeit / 16:30 Uhr Östlicher Zeit eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können teilnehmen, indem sie (800) 715-9871 oder (646) 307-1963 mit dem Konferenzcode 8740296 anrufen. Ein Live-Audio-Webcast wird über die Investor-Relations-Website verfügbar sein, mit einer anschließenden Aufzeichnung.
- None.
- None.
ALISO VIEJO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, will report financial results for the first quarter of 2025 after the market close on Wednesday, May 7, 2025. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
To participate in the conference call, please dial (800) 715-9871 or (646) 307-1963, and enter the conference code: 8740296. The call will also be broadcast live in listen-only mode via a link on the company’s investor relations website at https://investors.rxsight.com/. An archived recording of the call will be available through the same link shortly after its completion.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
When will RxSight (RXST) release its Q1 2025 earnings?
How can investors join RxSight's (RXST) Q1 2025 earnings call?
What time is RxSight's (RXST) Q1 2025 earnings call?
Where can I find the replay of RxSight's (RXST) Q1 2025 earnings call?
